Novel kinases and uses thereof
Abstract
Novel kinase polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length kinase proteins, the invention further provides isolated kinase fusion proteins, antigenic peptides, and anti-kinase antibodies. The invention also provides kinase nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a kinase gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.
Claims
exact text as granted — not AI-modified1 . An isolated polypeptide selected from the group consisting of:
a) a polypeptide comprising the amino acid sequence of SEQ ID NO:2; b) a polypeptide comprising a fragment of the amino acid sequence of SEQ ID NO:2, wherein the fragment has a kinase protein activity and comprises at least 75 contiguous amino acids of SEQ ID NO:2; c) a polypeptide having a kinase protein activity, wherein said polypeptide is encoded by a nucleic acid molecule comprising a nucleotide sequence that is at least 85% identical to SEQ ID NO:1, nucleotides 191-1156 of SEQ ID NO:1, or a complement thereof; and d) a polypeptide having a kinase protein activity, wherein the polypeptide is encoded by a nucleic acid molecule that hybridizes to a nucleic acid molecule comprising SEQ ID NO:1, nucleotides 191-1156 of SEQ ID NO:1, or a complement thereof under stringent conditions, said stringent conditions comprising hybridization in 6×SSC at 42° C., followed by washing with 1×SSC at 55° C.
2 . The isolated polypeptide of claim 1 comprising the amino acid sequence of SEQ ID NO:2.
3 . The polypeptide of claim 1 further comprising heterologous amino acid sequences.
4 . An antibody that selectively binds to a polypeptide of claim 1 .
5 . An isolated polypeptide comprising the amino acid sequence of SEQ ID NO:2.
6 . The polypeptide of claim 5 further comprising heterologous amino acid sequences.
7 . An antibody that selectively binds to the polypeptide of claim 5 .
8 . A polypeptide comprising a fragment of the amino acid sequence of SEQ ID NO:2, wherein the fragment has a kinase protein activity and comprises at least 75 contiguous amino acids of SEQ ID NO:2.
9 . The polypeptide of claim 8 further comprising heterologous amino acid sequences.
10 . An antibody that selectively binds to the polypeptide of claim 8 .
11 . A polypeptide having a kinase protein activity, wherein said polypeptide is encoded by a nucleic acid molecule comprising a nucleotide sequence that is at least 85% identical to SEQ ID NO:1, nucleotides 191-1156 of SEQ ID NO:1, or a complement thereof.
12 . The polypeptide of claim 11 further comprising heterologous amino acid sequences.
13 . An antibody that selectively binds to the polypeptide of claim 11 .
14 . A polypeptide having a kinase protein activity, wherein the polypeptide is encoded by a nucleic acid molecule that hybridizes to a nucleic acid molecule comprising SEQ ID NO:1, nucleotides 191-1156 of SEQ ID NO:1, or a complement thereof under stringent conditions, said stringent conditions comprising hybridization in 6×SSC at 42° C., followed by washing with 1×SSC at 55° C.
15 . The polypeptide of claim 14 further comprising heterologous amino acid sequences.
16 . An antibody that selectively binds to the polypeptide of claim 14.Join the waitlist — get patent alerts
Track US2005089917A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.